Patents by Inventor Paul Nakamura

Paul Nakamura has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for treatment of retinal disease by photoreceptor gene expression modulation
    Patent number: 10849904
    Abstract: Methods for decreasing rod gene expression in a retina, methods for decreasing the protein products expressed by rod genes in a retina, methods for treating a disease or condition treatable by decreasing rod gene expression or their protein products in a retina, and methods for treating a retinal disease in a subject.
    Type: Grant
    Filed: June 20, 2019
    Date of Patent: December 1, 2020
    Assignees: University of Washington, The J. David Gladstone Institutes, a Teatamentary Trust Established Under the Will of J. David. Gladstone
    Inventors: Thomas A. Reh, Paul Nakamura, Sheng Ding
  • PHOTORECEPTOR GENE MODULATOR PHOTOREGULIN 3 FOR TREATMENT OF RETINAL DISEASE
    Publication number: 20200368234
    Abstract: Methods for decreasing rod gene expression in a retina, methods for decreasing the protein products expressed by rod genes in a retina, methods for treating a disease or condition treatable by decreasing rod gene expression or their protein products in a retina, and methods for treating a retinal disease in a subject using Photoregulin3 (PR3).
    Type: Application
    Filed: August 10, 2018
    Publication date: November 26, 2020
    Applicants: University of Washington, The J. David Gladstone Institutes, a Testamentary Trust Established Under the Will of J David Gladst
    Inventors: Thomas A. Reh, Paul Nakamura, Andy Shimchuk, Shibing Tang, Sheng Ding
  • METHODS FOR TREATMENT OF RETINAL DISEASE BY PHOTORECEPTOR GENE EXPRESSION MODULATION
    Publication number: 20190381047
    Abstract: Methods for decreasing rod gene expression in a retina, methods for decreasing the protein products expressed by rod genes in a retina, methods for treating a disease or condition treatable by decreasing rod gene expression or their protein products in a retina, and methods for treating a retinal disease in a subject.
    Type: Application
    Filed: June 20, 2019
    Publication date: December 19, 2019
    Applicants: University of Washington, The J. David Gladstone Institutes, a Testamentary Trust Established Under the Will of J. David Glads
    Inventors: Thomas A. Reh, Paul Nakamura, Sheng Ding
  • Methods for treatment of retinal disease by photoreceptor gene expression modulation
    Patent number: 10363256
    Abstract: Methods for decreasing rod gene expression in a retina, methods for decreasing the protein products expressed by rod genes in a retina, methods for treating a disease or condition treatable by decreasing rod gene expression or their protein products in a retina, and methods for treating a retinal disease in a subject.
    Type: Grant
    Filed: March 28, 2016
    Date of Patent: July 30, 2019
    Assignees: University of Washington, The J. David Gladstone Institutes, a Testamentary Trust Established Under the Will of J. David Gladstone
    Inventors: Thomas A. Reh, Paul Nakamura, Sheng Ding
  • METHODS FOR TREATMENT OF RETINAL DISEASE BY PHOTORECEPTOR GENE EXPRESSION MODULATION
    Publication number: 20180125847
    Abstract: Methods for decreasing rod gene expression in a retina, methods for decreasing the protein products expressed by rod genes in a retina, methods for treating a disease or condition treatable by decreasing rod gene expression or their protein products in a retina, and methods for treating a retinal disease in a subject.
    Type: Application
    Filed: March 28, 2016
    Publication date: May 10, 2018
    Applicants: University of Washington, The J. David Gladstone Institutes, a Testamentary Trust Established Under the Will of J. David Glads
    Inventors: Thomas A. Reh, Paul Nakamura, Sheng Ding